Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa M Rimsza

Showing results (71-80 of 167) with videos related to

Pageof 17
Sort By:
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 19, 2007
Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphomaRobin A Roberts, Constantine M Sabalos, Michael L LeBlanc, et al.
Haematologica|April 11, 2020
Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphomaShamzah Araf, Koorosh Korfi, Findlay Bewicke-Copley, et al.
Blood|March 18, 2006
Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survivalRobin A Roberts, George Wright, Andreas R Rosenwald, et al.
British Journal of Haematology|August 11, 2018
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma NetworkHilka Rauert-Wunderlich, Anja Mottok, David W Scott, et al.
Blood Advances|October 25, 2019
Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphomaManali Kamdar, Hongli Li, Robert W Chen, et al.
Blood Advances|October 14, 2022
Transformation of FL into DLBCL with a PMBL gene expression signatureTristan Loveday, Gerben Duns, Lisa M Rimsza, et al.
British Journal of Haematology|April 14, 2016
Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704Soham D Puvvada, Patrick J Stiff, Michael Leblanc, et al.
Blood Advances|April 19, 2022
Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphomaDiego Villa, Eva Hoster, Olivier Hermine, et al.
Haematologica|July 7, 2017
Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assayJean-Philippe Jais, Thierry Jo Molina, Philippe Ruminy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissuesLisa M Rimsza, George Wright, Mark Schwartz, et al.
Pageof 17

Showing results (71-80 of 167) with videos related to

Sort By:
Pageof 17
Laboratory Investigation; a Journal of Technical Methods and Pathology|August 19, 2007
Quantitative nuclease protection assay in paraffin-embedded tissue replicates prognostic microarray gene expression in diffuse large-B-cell lymphomaRobin A Roberts, Constantine M Sabalos, Michael L LeBlanc, et al.
Haematologica|April 11, 2020
Genetic heterogeneity highlighted by differential FDG-PET response in diffuse large B-cell lymphomaShamzah Araf, Koorosh Korfi, Findlay Bewicke-Copley, et al.
Blood|March 18, 2006
Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survivalRobin A Roberts, George Wright, Andreas R Rosenwald, et al.
British Journal of Haematology|August 11, 2018
Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma NetworkHilka Rauert-Wunderlich, Anja Mottok, David W Scott, et al.
Blood Advances|October 25, 2019
Five-year outcomes of the S1106 study of R-hyper-CVAD vs R-bendamustine in transplant-eligible patients with mantle cell lymphomaManali Kamdar, Hongli Li, Robert W Chen, et al.
Blood Advances|October 14, 2022
Transformation of FL into DLBCL with a PMBL gene expression signatureTristan Loveday, Gerben Duns, Lisa M Rimsza, et al.
British Journal of Haematology|April 14, 2016
Outcomes of MYC-associated lymphomas after R-CHOP with and without consolidative autologous stem cell transplant: subset analysis of randomized trial intergroup SWOG S9704Soham D Puvvada, Patrick J Stiff, Michael Leblanc, et al.
Blood Advances|April 19, 2022
Bendamustine or high-dose cytarabine-based induction with rituximab in transplant-eligible mantle cell lymphomaDiego Villa, Eva Hoster, Olivier Hermine, et al.
Haematologica|July 7, 2017
Reliable subtype classification of diffuse large B-cell lymphoma samples from GELA LNH2003 trials using the Lymph2Cx gene expression assayJean-Philippe Jais, Thierry Jo Molina, Philippe Ruminy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2011
Accurate classification of diffuse large B-cell lymphoma into germinal center and activated B-cell subtypes using a nuclease protection assay on formalin-fixed, paraffin-embedded tissuesLisa M Rimsza, George Wright, Mark Schwartz, et al.
Pageof 17